Epidemiology, risk factors, prevention, and early detection of melanoma.

The incidence of melanoma has increased over the past several decades. Despite improved case mortality, overall deaths from melanoma have increased because of the large increase in incidence. Although we have a better understanding of the pathogenesis of melanoma and improved early diagnostic capabilities, the burden of disease and societal costs remain high. This article provides an update on the epidemiology of cutaneous melanoma worldwide and the common risk factors including heritable and modifiable risks, emphasizing the importance of education, early detection, and prevention in reducing the disease burden.

[1]  Lawrence E Gibson,et al.  Increasing incidence of melanoma among young adults: an epidemiological study in Olmsted County, Minnesota. , 2012, Mayo Clinic proceedings.

[2]  Amy Y. Chen,et al.  Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis. , 2008, The Lancet. Oncology.

[3]  A. Halpern,et al.  Patterns of detection in patients with cutaneous melanoma , 2000, Cancer.

[4]  D. Rigel,et al.  The Evolution of Melanoma Diagnosis: 25 Years Beyond the ABCDs , 2010, CA: a cancer journal for clinicians.

[5]  B. Gilchrest,et al.  The pathogenesis of melanoma induced by ultraviolet radiation. , 1999, The New England journal of medicine.

[6]  W. O. Jones,et al.  Incidence of Malignant Melanoma in Auckland, New Zealand: Highest Rates in the World , 1999, World Journal of Surgery.

[7]  S. Swetter,et al.  Factors related to the presentation of thin and thick nodular melanoma from a population‐based cancer registry in Queensland Australia , 2009, Cancer.

[8]  Tim K. Lee,et al.  Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls , 2009, International journal of epidemiology.

[9]  U. P. S. T. Force,et al.  Screening for skin cancer: U.S. Preventive Services Task Force recommendation statement. , 2009 .

[10]  S. Gandini,et al.  Reviews on sun exposure and artificial light and melanoma. , 2011, Progress in biophysics and molecular biology.

[11]  C. Balch,et al.  Melanoma in the Older Patient: Measuring Frailty as an Index of Survival , 2011, Annals of Surgical Oncology.

[12]  H. Adami,et al.  Obesity and risk of malignant melanoma: a meta-analysis of cohort and case-control studies. , 2013, European journal of cancer.

[13]  Sabine Siesling,et al.  Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. , 2008, European journal of cancer.

[14]  P. Boyle,et al.  Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. , 2005, European journal of cancer.

[15]  S. Swetter,et al.  The expanding melanoma burden in California hispanics , 2011, Cancer.

[16]  V. Moyer Behavioral Counseling to Prevent Skin Cancer: U.S. Preventive Services Task Force Recommendation Statement , 2012, Annals of Internal Medicine.

[17]  A. Qureshi,et al.  Personal history of prostate cancer and increased risk of incident melanoma in the United States. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  N. Hayward,et al.  Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. , 2003, Journal of the National Cancer Institute.

[19]  Ian Jackson,et al.  Variants of the melanocyte–stimulating hormone receptor gene are associated with red hair and fair skin in humans , 1995, Nature Genetics.

[20]  Ivana K. Kim,et al.  Germline BAP1 Inactivation Is Preferentially Associated with Metastatic Ocular Melanoma and Cutaneous-Ocular Melanoma Families , 2012, PloS one.

[21]  Kari Stefansson,et al.  ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma , 2008, Nature Genetics.

[22]  Donald R. Miller,et al.  Melanoma epidemic: an analysis of six decades of data from the Connecticut Tumor Registry. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  M. Weinstock,et al.  Do tanning lamps cause melanoma? An epidemiologic assessment. , 1998, Journal of the American Academy of Dermatology.

[24]  F. Sera,et al.  Hormonal and reproductive factors in relation to melanoma in women: current review and meta-analysis. , 2011, European journal of cancer.

[25]  Emily White,et al.  A cohort study of vitamin D intake and melanoma risk. , 2009, The Journal of investigative dermatology.

[26]  T. Fennell,et al.  Melanoma genome sequencing reveals frequent PREX2 mutations , 2012, Nature.

[27]  J. Aitken,et al.  Trends for in situ and Invasive Melanoma in Queensland, Australia, 1982–2002 , 2006, Cancer Causes & Control.

[28]  P. Boyle,et al.  Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. , 2005, European journal of cancer.

[29]  S. Puig,et al.  Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents , 2006, Journal of Medical Genetics.

[30]  A. Halpern,et al.  Reducing mortality in individuals at high risk for advanced melanoma through education and screening. , 2011, Journal of the American Academy of Dermatology.

[31]  O. Gefeller,et al.  Malignant Melanoma of the Skin: Long-term Follow-up and Time to First Recurrence , 2011, World Journal of Surgery.

[32]  R. Stern,et al.  Incidence of skin cancer in 5356 patients following organ transplantation , 2000, The British journal of dermatology.

[33]  R. Liu,et al.  Meta-analysis of the relationship between Parkinson disease and melanoma , 2011, Neurology.

[34]  Myles G Cockburn,et al.  Increasing burden of melanoma in the United States. , 2009, The Journal of investigative dermatology.

[35]  M. Weinstock,et al.  Does skin cancer screening save lives? , 2012, Cancer.

[36]  B K Armstrong,et al.  Epidemiology of malignant melanoma: intermittent or total accumulated exposure to the sun? , 1988, The Journal of dermatologic surgery and oncology.

[37]  A. Halpern,et al.  Cutaneous melanoma risk and phenotypic changes in large congenital nevi: a follow-up study of 46 patients. , 1998, Journal of the American Academy of Dermatology.

[38]  H. Curtis Biological mechanisms underlying the aging process. , 1963, Science.

[39]  A. Kopf,et al.  Early detection of malignant melanoma: The role of physician examination and self‐examination of the skin , 1985, CA: a cancer journal for clinicians.

[40]  Jessica King,et al.  Racial and ethnic variations in incidence and survival of cutaneous melanoma in the United States, 1999-2006. , 2011, Journal of the American Academy of Dermatology.

[41]  D. Easton,et al.  Lifetime risks of common cancers among retinoblastoma survivors. , 2004, Journal of the National Cancer Institute.

[42]  A. Jemal,et al.  Cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.

[43]  J. Brewer,et al.  Iatrogenic immunosuppression and cutaneous malignancy. , 2011, Clinics in dermatology.

[44]  J. Fridlyand,et al.  Distinct sets of genetic alterations in melanoma. , 2005, The New England journal of medicine.

[45]  S. Swetter,et al.  California Medicaid enrollment and melanoma stage at diagnosis: a population-based study. , 2008, American journal of preventive medicine.

[46]  S. Swetter,et al.  Melanoma underreporting: why does it happen, how big is the problem, and how do we fix it? , 2008, Journal of the American Academy of Dermatology.

[47]  Manuel Serrano,et al.  The common biology of cancer and ageing , 2007, Nature.

[48]  Jacqueline Whetteckey,et al.  Malignant melanoma and levodopa in Parkinson's disease: causality or coincidence? , 2003, Parkinsonism & related disorders.

[49]  C. Balch,et al.  Epidemiology and treatment of melanoma in elderly patients , 2010, Nature Reviews Clinical Oncology.

[50]  A. Halpern,et al.  Overcoming obstacles to skin cancer examinations and prevention counseling for high-risk patients: results of a national survey of primary care physicians. , 2004, The Journal of the American Board of Family Practice.

[51]  Xianglin L. Du,et al.  Ethnic differences among patients with cutaneous melanoma. , 2006, Archives of internal medicine.

[52]  Sean Davis,et al.  Interferon-γ links ultraviolet radiation to melanomagenesis in mice. , 2011, Nature.

[53]  D. Jukic,et al.  Pediatric melanoma: Analysis of an international registry , 2013, Cancer.

[54]  A. Berghold,et al.  Calcinosis cutis: part I. Diagnostic pathway. , 2011, Journal of the American Academy of Dermatology.

[55]  G. Belch,et al.  Promotion of frequent tanning sessions by indoor tanning facilities: two studies. , 2002, Journal of the American Academy of Dermatology.

[56]  F. Sera,et al.  Meta-analysis of risk factors for cutaneous melanoma according to anatomical site and clinico-pathological variant. , 2009, European journal of cancer.

[57]  L. Bemis,et al.  miR in melanoma development: miRNAs and acquired hallmarks of cancer in melanoma. , 2013, Physiological genomics.

[58]  Gail M Williams,et al.  Reduced melanoma after regular sunscreen use: randomized trial follow-up. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[59]  N. Hayward,et al.  Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma , 1996, Nature Genetics.

[60]  D. Fisher,et al.  Stemming the tanning bed epidemic: time for action. , 2012, Journal of the National Comprehensive Cancer Network : JNCCN.

[61]  Jennifer S. Lin,et al.  Behavioral Counseling to Prevent Skin Cancer: A Systematic Review for the U.S. Preventive Services Task Force , 2011, Annals of Internal Medicine.

[62]  Boice Jd,et al.  Second cancer following cutaneous melanoma and cancers of the brain, thyroid, connective tissue, bone, and eye in Connecticut, 1935-82. , 1985 .

[63]  R. Scott,et al.  Xeroderma pigmentosum genes and melanoma risk , 2013, International journal of cancer.

[64]  Alan Geller,et al.  Visual screening for malignant melanoma: a cost-effectiveness analysis. , 2007, Archives of dermatology.

[65]  N Cascinelli,et al.  Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[66]  Risk factors for cutaneous melanoma. A practical method of recognizing predisposed individuals. , 1987 .

[67]  J. Belsky,et al.  The health and development of children born to older mothers in the United Kingdom: observational study using longitudinal cohort data , 2012, BMJ : British Medical Journal.

[68]  J. Fulton,et al.  Reporting cutaneous melanoma to cancer registries in the United States. , 2003, Journal of the American Academy of Dermatology.

[69]  J. Goodwin,et al.  Socioeconomic Status and Survival in Older Patients with Melanoma , 2006, Journal of the American Geriatrics Society.

[70]  D. English,et al.  Clinical whole‐body skin examination reduces the incidence of thick melanomas , 2009, International journal of cancer.

[71]  C. Balch,et al.  Melanoma in children and teenagers: an analysis of patients from the National Cancer Data Base. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[72]  David Polsky,et al.  Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria. , 2004, JAMA.

[73]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[74]  P. Boyle,et al.  Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. , 2005, European journal of cancer.

[75]  G. Armstrong,et al.  Melanoma as a subsequent neoplasm in adult survivors of childhood cancer: A report from the childhood cancer survivor study , 2013, Pediatric blood & cancer.

[76]  F. Sera,et al.  MC1R variants, melanoma and red hair color phenotype: A meta‐analysis , 2008, International journal of cancer.

[77]  V. Sondak,et al.  Age as a Prognostic Factor in Patients with Localized Melanoma and Regional Metastases , 2013, Annals of Surgical Oncology.

[78]  D. Schadendorf,et al.  Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma , 2014, Nature.

[79]  A. Geller Educational and screening campaigns to reduce deaths from melanoma. , 2009, Hematology/oncology clinics of North America.

[80]  B. Meiser,et al.  Skin cancer-related prevention and screening behaviors: a review of the literature , 2009, Journal of Behavioral Medicine.

[81]  J. Kładny,et al.  Common variants of DNA repair genes and malignant melanoma. , 2008, European journal of cancer.

[82]  K. Freedberg,et al.  Screening for malignant melanoma: A cost-effectiveness analysis. , 1999, Journal of the American Academy of Dermatology.

[83]  C. la Vecchia,et al.  Cancer risk in women with previous breast cancer. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[84]  E. Chang,et al.  Nonsteroidal anti‐inflammatory drugs and the risk of skin cancer , 2012, Cancer.

[85]  A. Kopf,et al.  RISK GRADIENT FOR MALIGNANT MELANOMA IN INDIVIDUALS WITH DYSPLASTIC NAEVI , 1988, The Lancet.

[86]  B. Wood Desmoplastic melanoma: recent advances and persisting challenges , 2013, Pathology.

[87]  A. Swerdlow,et al.  The risk of melanoma in patients with congenital nevi: a cohort study. , 1995, Journal of the American Academy of Dermatology.

[88]  S. Gruber,et al.  Is physician detection associated with thinner melanomas? , 1999, JAMA.

[89]  F. Hodi,et al.  Molecular genetics of familial cutaneous melanoma. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[90]  P. Duray,et al.  Neonatal sunburn and melanoma in mice , 2001, Nature.

[91]  G. Ziegelberger,et al.  International commission on non-ionizing radiation protection. , 2006, Progress in biophysics and molecular biology.

[92]  Glenn Merlino,et al.  Ultraviolet radiation and cutaneous malignant melanoma , 2003, Oncogene.

[93]  Peter Boyle,et al.  Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis , 2012, BMJ : British Medical Journal.

[94]  J. Lortet-Tieulent,et al.  International trends in the incidence of malignant melanoma 1953–2008—are recent generations at higher or lower risk? , 2013, International journal of cancer.

[95]  Christopher F. Martin,et al.  Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease. , 2012, Gastroenterology.

[96]  Donald R. Miller,et al.  The first 15 years of the American Academy of Dermatology skin cancer screening programs: 1985-1999. , 2003, Journal of the American Academy of Dermatology.

[97]  K. Brown,et al.  A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma , 2011, Nature.

[98]  A. Weaver,et al.  Malignant melanoma in solid transplant recipients: collection of database cases and comparison with surveillance, epidemiology, and end results data for outcome analysis. , 2011, Archives of dermatology.

[99]  B. Cox,et al.  A comparison of trends in melanoma mortality in New Zealand and Australia: the two countries with the highest melanoma incidence and mortality in the world , 2013, BMC Cancer.

[100]  L. Tryggvadottir,et al.  A melanoma epidemic in Iceland: possible influence of sunbed use. , 2010, American journal of epidemiology.

[101]  T. Polascik,et al.  Characteristics of patients diagnosed with both melanoma and renal cell cancer , 2013, Cancer Causes and Control.

[102]  J R Eiser,et al.  Is targeted early detection for melanoma feasible? Self assessments of risk and attitudes to screening , 2000, Journal of medical screening.

[103]  E. Schernhammer,et al.  Parkinson’s disease and cancer risk: a systematic review and meta-analysis , 2010, Cancer Causes & Control.

[104]  A. Sivachenko,et al.  A Landscape of Driver Mutations in Melanoma , 2012, Cell.

[105]  Donald R. Miller,et al.  Melanoma incidence and mortality among US whites, 1969-1999. , 2002, JAMA.

[106]  A. Sober,et al.  An estimate of the annual direct cost of treating cutaneous melanoma. , 1998, Journal of the American Academy of Dermatology.

[107]  Jennifer L. Schwartz,et al.  Thin primary cutaneous melanomas , 2002, Cancer.

[108]  T. Fears,et al.  Pediatric melanoma: risk factor and survival analysis of the surveillance, epidemiology and end results database. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[109]  W. Clark,et al.  High risk of malignant melanoma in melanoma-prone families with dysplastic nevi. , 1985, Annals of internal medicine.